Stay updated with breaking news from Immvira ov. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ On August 1, 2022, U.S. time, ImmVira s brand new oncolytic herpes simplex virus ("oHSV") product MVR-C5252 targeting Malignant Glioma has. ....